Science 37 to Present at the Baird 2022 Global Healthcare Conference

Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) announced its participation in the Baird Global Healthcare Conference in New York, scheduled for September 13, 2022, at 3:45 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the company's Investor Relations webpage.

Science 37 aims to improve access to clinical research through its Agile Clinical Trial Operating System™, enhancing the speed and diversity of patient enrollment while supporting decentralized clinical trials.

RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37^® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York.

Science 37’s management is scheduled to present on Tuesday, September 13, 2022, at 3:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://investors.science37.com.

About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 l Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 21x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization. For more information, visit https://www.science37.com.

MEDIA INQUIRIES

Drew Bustos
Science 37
Phone: (984) 377-3737
Email: pr@science37.com

INVESTOR RELATIONS:
Caroline Paul
Gilmartin Group
Investors@science37.com

FAQ

When is Science 37's presentation at the Baird Global Healthcare Conference?

Science 37's presentation is scheduled for September 13, 2022, at 3:45 p.m. Eastern Time.

How can I access the Science 37 conference presentation?

The presentation can be accessed via a live and archived webcast on the Investor Relations section of Science 37's website.

What is the goal of Science 37?

Science 37 aims to enable universal access to clinical research, facilitating patient and provider participation in clinical trials.

What benefits does Science 37's platform offer?

The platform enables up to 21x faster enrollment, 28% better retention, and a 3x more diverse patient population for clinical trials.

What is the ticker symbol for Science 37?

The ticker symbol for Science 37 is SNCE.